XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is…
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is…
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is…
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive…
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive…
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
– Phase 1 data for CT-388, a once-weekly injectable, dual GLP-1/GIP receptor agonist in development…
– Phase 1 data for CT-388, a once-weekly injectable, dual GLP-1/GIP receptor agonist in development…
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (NASDAQ:…
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (NASDAQ:…
–Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population…
Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE…
–Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population…
Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE…
Provides a look at the new manufacturing facility in Huntsville, Alabama Introduced as part of…
Provides a look at the new manufacturing facility in Huntsville, Alabama Introduced as part of…
In-person event and virtual webcast to be held on Sunday, October 22, 2023 at 8:00pm…
In-person event and virtual webcast to be held on Sunday, October 22, 2023 at 8:00pm…
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces…
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces…